ThesisTimes
TimesDiscover
Log inSign up free
Sign up

Features

All featuresPlatform capabilities in one catalog.
  • Copilot
  • Portfolio Analytics
  • Research
  • Inbox
  • Dashboards
  • Charting
  • Options

For investors

Browse by investor typeSee Thesis framed for how you manage money.
  • Concentrated portfolios
  • Covered call investors
  • Busy professionals
  • Stock research
  • Swing traders
  • Options beginners
TimesDiscover
Log inSign up free

Market analysis for active investors

Thesis Times

Saturday, June 6, 2026·1 stories

AllAMGNDJIGOOGLLLYABTABVXALBAPOARESASHRBABX

Front page

Biotech & Clinical Trials·Jun 2

Abivax Shares Crater 32% After Bowel Disease Drug Trial Disappoints

A brutal single-session selloff wipes out a third of ABVX's market value as clinical data on its lead inflammatory bowel disease asset falls short of expectations.

ABVX

Biotech & Clinical Trials·Jun 2

Abivax Shares Crater 32% After Bowel Disease Drug Trial Disappoints

A brutal single-session selloff wipes out a third of ABVX's market value as clinical data on its lead inflammatory bowel disease asset falls short of expectations.

ABVX

Features·Discover·Terms·Privacy